166 related articles for article (PubMed ID: 34816752)
1. Functional metagenomic profile of the lacrimal sac microbial communities in primary acquired nasolacrimal duct obstruction: The Lacriome paper 2.
Ali MJ
Eur J Ophthalmol; 2022 Jul; 32(4):2059-2066. PubMed ID: 34816752
[TBL] [Abstract][Full Text] [Related]
2. Metagenomics of the lacrimal sac in primary acquired nasolacrimal duct obstruction: the Lacriome paper 1.
Ali MJ
Br J Ophthalmol; 2023 Jan; 107(1):147-150. PubMed ID: 34261660
[TBL] [Abstract][Full Text] [Related]
3. Alterations of Lacrimal Sac Microbiota in Failed Dacryocystorhinostomy: The Lacriome Paper 6.
Ali MJ
Semin Ophthalmol; 2024 May; 39(4):324-329. PubMed ID: 38461372
[TBL] [Abstract][Full Text] [Related]
4. Fungal microbiome (mycobiome) and virome of the lacrimal sac in patients with PANDO: the lacriome paper 5.
Ali MJ
Br J Ophthalmol; 2024 Jan; 108(2):317-322. PubMed ID: 36270766
[TBL] [Abstract][Full Text] [Related]
5. Microbial Metagenomics of the Extubated Lacrimal Stents Following Dacryocystorhinostomy: The Lacriome Paper 4.
Ali MJ
Ophthalmic Plast Reconstr Surg; 2022 Nov-Dec 01; 38(6):558-562. PubMed ID: 35470322
[TBL] [Abstract][Full Text] [Related]
6. Metagenomics of infective canaliculitis: The Lacriome paper 3.
Ali MJ
Eur J Ophthalmol; 2022 Nov; 32(6):3346-3352. PubMed ID: 35354326
[TBL] [Abstract][Full Text] [Related]
7. Viral nucleic acid analysis with PCR in lacrimal tissue and nasal swab samples of primary acquired nasolacrimal duct obstruction cases.
Yanık Ö; Hoşal B; Tekeli A; Nalcı H
Eur J Ophthalmol; 2021 Jan; 31(1):138-143. PubMed ID: 31630558
[TBL] [Abstract][Full Text] [Related]
8. Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
Makselis A; Petroska D; Kadziauskiene A; Jaruseviciene R; Ruzgys A; Cimbalas A; Besusparis J; Asoklis RS
BMC Ophthalmol; 2022 Jan; 22(1):12. PubMed ID: 34986808
[TBL] [Abstract][Full Text] [Related]
9. The Microbiome of the Nasolacrimal System and Its Role in Nasolacrimal Duct Obstruction.
Curragh DS; Bassiouni A; Macias-Valle L; Vreugde S; Wormald PJ; Selva D; Psaltis AJ
Ophthalmic Plast Reconstr Surg; 2020; 36(1):80-85. PubMed ID: 31809480
[TBL] [Abstract][Full Text] [Related]
10. Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients.
Tucker N; Chow D; Stockl F; Codère F; Burnier M
Ophthalmology; 1997 Nov; 104(11):1882-6. PubMed ID: 9373121
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the dacryoscintigraphy in patients with nasolacrimal duct obstruction prior to endoscopic dacryocystorhinostomy.
Kim DJ; Baek S; Chang M
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1535-1540. PubMed ID: 31037489
[TBL] [Abstract][Full Text] [Related]
12. [Rosenmüller valve during endoscopic dacryocystorhinostomy in treating refractory nasolacrimal duct obstruction].
Wang M; Wang SQ; Zhang J; Li MW; Xing ZM; Yuan XP; Li H; Liu Y; Geng CL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):522-7. PubMed ID: 27480301
[TBL] [Abstract][Full Text] [Related]
13. Altered Surfactant Protein Expression in Primary Acquired Nasolacrimal Duct Obstruction.
Ali MJ; Bráuer L; Schicht M; Paulsen F
Ophthalmic Plast Reconstr Surg; 2019; 35(6):553-557. PubMed ID: 30882588
[TBL] [Abstract][Full Text] [Related]
14. Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
Ali MJ
Prog Retin Eye Res; 2023 Sep; 96():101193. PubMed ID: 37394093
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of indocyanine green gel in the identification and complete removal of the medial wall of the lacrimal sac during endoscopic endonasal dacryocystorhinostomy.
Park J; Lee J; Lee H; Baek S
Can J Ophthalmol; 2017 Oct; 52(5):494-498. PubMed ID: 28985810
[TBL] [Abstract][Full Text] [Related]
16. Bacteriological profile in conjunctival, lacrimal sac, and nasal specimens and conjunctival normalization time following external, endoscopic, and transcanalicular multidiode laser dacryocystorhinostomy.
Balikoglu-Yilmaz M; Esen AB; Yilmaz T; Taskin U; Taskapili M; Oktay MF; Sen E; Kose T
Arq Bras Oftalmol; 2016; 79(3):163-70. PubMed ID: 27463627
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin expression in the lacrimal sac of patients with primary and functional nasolacrimal duct obstruction.
Park J; Kim J; Kim M; Baek S
Br J Ophthalmol; 2017 Apr; 101(4):519-524. PubMed ID: 27439740
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
Yazici B; Yazici Z; Parlak M
Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
Ng DS; Chan E; Tong FM; Chow SK; Ko ST
Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study of lacrimal sac and nasal mucosa in 44 patients with complete acquired nasolacrimal duct obstruction.
Mauriello JA; Palydowycz S; DeLuca J
Ophthalmic Plast Reconstr Surg; 1992; 8(1):13-21. PubMed ID: 1554647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
